Drug class
Second-generation sulfonylurea oral antidiabetic
Mechanism of action
Stimulates insulin secretion from pancreatic beta cells by binding the sulfonylurea receptor (SUR1) and closing ATP-sensitive potassium channels, leading to membrane depolarisation, calcium influx and insulin release. It also has reported haemovascular effects.
General use cases
- Treatment of type 2 diabetes mellitus in adults when dietary measures, exercise and weight reduction alone are insufficient
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
